Lv7
4579 积分 2021-05-07 加入
Treatment of refractory or relapsed myelodysplastic neoplasms with luspatercept: a multicenter Chinese study
15天前
已完结
Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes
15天前
已完结
Luspatercept for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes (PACE-MDS): a multicentre, open-label phase 2 dose-finding study with long-term extension study
15天前
已完结
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia
15天前
已完结
Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial
15天前
已完结
Luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): primary analysis of a phase 3, open-label, randomised, controlled trial
15天前
已完结
颅内罕见巨大金属异物手术治疗的体会
20天前
已完结
颅内动脉瘤术中破裂的防范及处理措施
20天前
已完结
Exploring the molecular mechanism of notoginsenoside R1 in sepsis-induced cardiomyopathy based on network pharmacology and experiments validation
1个月前
已完结
Notoginsenoside R1 attenuates idiopathic pulmonary fibrosis through neuropilin-1/type 2 innate lymphoid cells pathway
1个月前
已完结
皖公网安备34019202002308
